Baker Bros. Decreases Exposure at Viropharma

Julian and Felix Baker‘s hedge fund, Baker Bros. Advisors, now holds around 4.4 million shares of Viropharma Inc (NASDAQ:VPHM), a newly amended filing with the SEC has revealed. Baker Bros. has almost halved its exposure at the company from some 8.3 million shares disclosed in an earlier filing. The new stake amasses 6.7% of Viropharma’s outstanding stock.

Viropharma Inc (NASDAQ:VPHM)

Disclosure: none

Recommended Reading:

Earnest Partners Decreases Position in Astoria Financial Corp; Ups Stake in Meritage Homes Corp

Mario Gabelli, Gamco Buy More Shares of Edgen Group

Palo Alto Investors Sells Out Of Savient Pharmaceuticals